Literature DB >> 21704032

Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes.

Natalya S Petrova1, Mariya I Meschaninova, Alya G Venyaminova, Marina A Zenkova, Valentin V Vlassov, Elena L Chernolovskaya.   

Abstract

The thermodynamic properties of siRNA duplexes are important for their silencing activity. siRNAs with high thermodynamic stability of both the central part of the duplex and in the whole, usually display low silencing activity. Destabilization of the central part of the siRNA duplex could increase its silencing activity. However, mismatches located in the central part of the duplex could substantially decrease the amount of RNAi efficacy, hindering active RISC formation and function. In this study, we examined the impact of duplex destabilization by nucleotide substitutions in the central part (7-10 nt counting from the 5'-end of the antisense strand) of the nuclease-resistant siRNA on its silencing activity.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704032     DOI: 10.1016/j.febslet.2011.06.003

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Therapeutic potential of chemically modified siRNA: Recent trends.

Authors:  Chelliah Selvam; Daniel Mutisya; Sandhya Prakash; Kasturi Ranganna; Ramasamy Thilagavathi
Journal:  Chem Biol Drug Des       Date:  2017-05-16       Impact factor: 2.817

2.  Conjugation and Evaluation of Small Hydrophobic Molecules to Triazole-Linked siRNAs.

Authors:  Brandon J Peel; Gordon Hagen; Kalaivani Krishnamurthy; Jean-Paul Desaulniers
Journal:  ACS Med Chem Lett       Date:  2014-12-04       Impact factor: 4.345

3.  Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid-siRNA conjugates.

Authors:  Lidya Salim; Golam Islam; Jean-Paul Desaulniers
Journal:  Nucleic Acids Res       Date:  2020-01-10       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.